ID WNT8_XENLA Reviewed; 358 AA. AC P28026; DT 01-AUG-1992, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1996, sequence version 2. DT 27-MAR-2024, entry version 128. DE RecName: Full=Protein Wnt-8; DE Short=XWnt-8; DE Flags: Precursor; GN Name=wnt8; OS Xenopus laevis (African clawed frog). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus. OX NCBI_TaxID=8355; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Neurula; RX PubMed=1879349; DOI=10.1242/dev.111.4.1045; RA Christian J.L., McMahon J.A., McMahon A.P., Moon R.T.; RT "Xwnt-8, a Xenopus Wnt-1/int-1-related gene responsive to mesoderm-inducing RT growth factors, may play a role in ventral mesodermal patterning during RT embryogenesis."; RL Development 111:1045-1055(1991). RN [2] RP SEQUENCE REVISION TO C-TERMINUS. RX PubMed=7635061; DOI=10.1242/dev.121.7.2177; RA Cui Y., Brown J.D., Moon R.T., Christian J.L.; RT "Xwnt-8b: a maternally expressed Xenopus Wnt gene with a potential role in RT establishing the dorsoventral axis."; RL Development 121:2177-2186(1995). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 181-321. RC TISSUE=Neurula; RX PubMed=1991549; DOI=10.1016/0012-1606(91)90073-c; RA Christian J.L., Gavin B.J., McMahon A.P., Moon R.T.; RT "Isolation of cDNAs partially encoding four Xenopus Wnt-1/int-1-related RT proteins and characterization of their transient expression during RT embryonic development."; RL Dev. Biol. 143:230-234(1991). RN [4] RP FUNCTION. RX PubMed=7906224; DOI=10.1002/j.1460-2075.1994.tb06268.x; RA Cunliffe V., Smith J.C.; RT "Specification of mesodermal pattern in Xenopus laevis by interactions RT between Brachyury, noggin and Xwnt-8."; RL EMBO J. 13:349-359(1994). RN [5] RP INTERACTION WITH CER1. RX PubMed=10067895; DOI=10.1038/17820; RA Piccolo S., Agius E., Leyns L., Bhattacharyya S., Grunz H., Bouwmeester T., RA De Robertis E.M.; RT "The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP RT and Wnt signals."; RL Nature 397:707-710(1999). RN [6] RP PROTEOLYTIC PROCESSING BY TIKI1 AND TIKI2, AND SUBUNIT. RX PubMed=22726442; DOI=10.1016/j.cell.2012.04.039; RA Zhang X., Abreu J.G., Yokota C., Macdonald B.T., Singh S., Coburn K.L., RA Cheong S.M., Zhang M.M., Ye Q.Z., Hang H.C., Steen H., He X.; RT "Tiki1 is required for head formation via Wnt cleavage-oxidation and RT inactivation."; RL Cell 149:1565-1577(2012). RN [7] RP X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 23-338 IN COMPLEX WITH MOUSE RP FZD8, GLYCOSYLATION AT ASN-104 AND ASN-263, PALMITOLEOYLATION AT SER-187, RP AND DISULFIDE BONDS. RX PubMed=22653731; DOI=10.1126/science.1222879; RA Janda C.Y., Waghray D., Levin A.M., Thomas C., Garcia K.C.; RT "Structural basis of Wnt recognition by Frizzled."; RL Science 337:59-64(2012). CC -!- FUNCTION: Ligand for members of the frizzled family of seven CC transmembrane receptors. Plays a role in ventral mesodermal patterning CC during embryogenesis. Mimics Nieuwkoop center activity. Causes dorsal CC mesodermal differentiation of animal cap ectoderm when coexpressed with CC noggin and nuclear, sequence-specific DNA-binding protein xBra. None of CC these molecules causes dorsal mesoderm formation when expressed alone. CC {ECO:0000269|PubMed:7906224}. CC -!- SUBUNIT: Homooligomer; disulfide-linked, leading to inactivation. CC Interacts with the long chain of cer1. {ECO:0000269|PubMed:10067895, CC ECO:0000269|PubMed:22653731, ECO:0000269|PubMed:22726442}. CC -!- INTERACTION: CC P28026; Q6PA07: ptk7.L; NbExp=2; IntAct=EBI-6257743, EBI-7036323; CC P28026; Q61091: Fzd8; Xeno; NbExp=3; IntAct=EBI-6257743, EBI-6171689; CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix. CC -!- DEVELOPMENTAL STAGE: Mid-blastula, decline by tailbud. CC -!- PTM: Palmitoleoylation is required for efficient binding to frizzled CC receptors (PubMed:22653731). Depalmitoleoylation leads to Wnt signaling CC pathway inhibition (By similarity). {ECO:0000250|UniProtKB:P56704, CC ECO:0000269|PubMed:22653731}. CC -!- PTM: Proteolytic processing by tiki1 and tiki2 promotes oxidation and CC formation of large disulfide-bond oligomers, leading to inactivation of CC wnt8. {ECO:0000269|PubMed:22726442}. CC -!- SIMILARITY: Belongs to the Wnt family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA50012.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X57234; CAA40510.1; -; mRNA. DR EMBL; M55058; AAA50012.1; ALT_SEQ; mRNA. DR PIR; S18771; S18771. DR RefSeq; NP_001081637.1; NM_001088168.1. DR PDB; 4F0A; X-ray; 3.25 A; B=23-338. DR PDB; 8CTG; EM; 3.80 A; B=22-329. DR PDBsum; 4F0A; -. DR PDBsum; 8CTG; -. DR AlphaFoldDB; P28026; -. DR EMDB; EMD-26989; -. DR SMR; P28026; -. DR BioGRID; 99305; 1. DR IntAct; P28026; 3. DR MINT; P28026; -. DR GlyCosmos; P28026; 3 sites, No reported glycans. DR iPTMnet; P28026; -. DR DNASU; 397970; -. DR GeneID; 397970; -. DR KEGG; xla:397970; -. DR AGR; Xenbase:XB-GENE-866281; -. DR CTD; 397970; -. DR Xenbase; XB-GENE-866281; wnt8a.L. DR OrthoDB; 2874082at2759; -. DR Proteomes; UP000186698; Chromosome 3L. DR Bgee; 397970; Expressed in gastrula and 3 other cell types or tissues. DR GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:BHF-UCL. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005109; F:frizzled binding; IPI:ParkinsonsUK-UCL. DR GO; GO:0002020; F:protease binding; IPI:ParkinsonsUK-UCL. DR GO; GO:0009948; P:anterior/posterior axis specification; IMP:BHF-UCL. DR GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL. DR GO; GO:0000578; P:embryonic axis specification; IMP:BHF-UCL. DR GO; GO:2000044; P:negative regulation of cardiac cell fate specification; IMP:BHF-UCL. DR GO; GO:0014034; P:neural crest cell fate commitment; IMP:BHF-UCL. DR GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:BHF-UCL. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL. DR GO; GO:0060061; P:Spemann organizer formation; IMP:BHF-UCL. DR GO; GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL. DR CDD; cd19351; Wnt_Wnt8a; 1. DR Gene3D; 3.30.2460.20; -; 1. DR InterPro; IPR034312; Protein_Wnt-8A/8C. DR InterPro; IPR005817; Wnt. DR InterPro; IPR013301; Wnt8. DR InterPro; IPR043158; Wnt_C. DR InterPro; IPR018161; Wnt_CS. DR PANTHER; PTHR12027:SF92; PROTEIN WNT-8A; 1. DR PANTHER; PTHR12027; WNT RELATED; 1. DR Pfam; PF00110; wnt; 1. DR PRINTS; PR01892; WNT8PROTEIN. DR PRINTS; PR01349; WNTPROTEIN. DR SMART; SM00097; WNT1; 1. DR PROSITE; PS00246; WNT1; 1. PE 1: Evidence at protein level; KW 3D-structure; Developmental protein; Disulfide bond; Extracellular matrix; KW Glycoprotein; Lipoprotein; Reference proteome; Secreted; Signal; KW Wnt signaling pathway. FT SIGNAL 1..22 FT /evidence="ECO:0000255" FT CHAIN 23..358 FT /note="Protein Wnt-8" FT /id="PRO_0000041447" FT SITE 39..40 FT /note="Cleavage; by tiki1 and tiki2" FT /evidence="ECO:0000269|PubMed:22726442" FT SITE 42..43 FT /note="Cleavage; by tiki1 and tiki2" FT /evidence="ECO:0000269|PubMed:22726442" FT LIPID 187 FT /note="O-palmitoleoyl serine" FT /evidence="ECO:0000269|PubMed:22653731" FT CARBOHYD 104 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT CARBOHYD 263 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT CARBOHYD 282 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 55..66 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 105..113 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 115..133 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 181..195 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 183..190 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 260..298 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 276..291 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 295..337 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 313..328 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 315..325 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT DISULFID 320..321 FT /evidence="ECO:0000269|PubMed:22653731, FT ECO:0007744|PDB:4F0A" FT CONFLICT 243 FT /note="S -> T (in Ref. 3; AAA50012)" FT /evidence="ECO:0000305" FT CONFLICT 292 FT /note="K -> R (in Ref. 3; AAA50012)" FT /evidence="ECO:0000305" FT HELIX 34..58 FT /evidence="ECO:0007829|PDB:4F0A" FT TURN 59..61 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 62..64 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 72..75 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 84..106 FT /evidence="ECO:0007829|PDB:4F0A" FT TURN 107..109 FT /evidence="ECO:0007829|PDB:4F0A" FT TURN 118..121 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 122..125 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 128..130 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 137..151 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 154..156 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 157..175 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 178..183 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 186..188 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 192..198 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 202..214 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 236..243 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 247..249 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 261..263 FT /evidence="ECO:0007829|PDB:4F0A" FT TURN 264..267 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 285..288 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 290..294 FT /evidence="ECO:0007829|PDB:4F0A" FT HELIX 296..298 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 301..312 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 319..321 FT /evidence="ECO:0007829|PDB:4F0A" FT STRAND 327..338 FT /evidence="ECO:0007829|PDB:4F0A" SQ SEQUENCE 358 AA; 40176 MW; 8BC8B9E20016E504 CRC64; MQNTTLFILA TLLIFCPFFT ASAWSVNNFL MTGPKAYLTY SASVAVGAQN GIEECKYQFA WERWNCPEST LQLATHNGLR SATRETSFVH AISSAGVMYT LTRNCSMGDF DNCGCDDSRN GRIGGRGWVW GGCSDNAEFG ERISKLFVDG LETGQDARAL MNLHNNEAGR LAVKETMKRT CKCHGISGSC SIQTCWLQLA EFRDIGNHLK IKHDQALKLE MDKRKMRSGN SADNRGAIAD AFSSVAGSEL IFLEDSPDYC LKNISLGLQG TEGRECLQSG KNLSQWERRS CKRLCTDCGL RVEEKKTEII SSCNCKFHWC CTVKCEQCKQ VVIKHFCARR ERDSNMLNTK RKNRGHRR //